4//SEC Filing
Hippel James 4
Accession 0001062993-24-015387
CIK 0000842023other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 5:30 PM ET
Size
26.1 KB
Accession
0001062993-24-015387
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Hippel James
Chief Financial Officer
Transactions
- Award
Performance Restricted Stock Units
2024-08-15+24,062→ 24,062 total→ Common Stock (24,062 underlying) - Award
Restricted Stock Units
2024-08-15+12,031→ 12,031 total→ Common Stock (12,031 underlying) - Award
Stock Options (Right to Buy)
2024-08-15+32,417→ 32,417 totalExercise: $74.91Exp: 2034-08-15→ Common Stock (32,417 underlying)
Holdings
- 186,068
Stock Options (Right to Buy)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (186,068 underlying) - 99,926
Common Stock
- 53,867
Stock Options (Right to Buy)
Exercise: $31.26Exp: 2024-08-09→ Common Stock (53,867 underlying) - 168,620
Stock Options (Right to Buy)
Exercise: $44.33Exp: 2025-08-08→ Common Stock (168,620 underlying) - 167,328
Stock Options (Right to Buy)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (167,328 underlying) - 40,536
Stock Options (Right to Buy)
Exercise: $120.46Exp: 2028-08-06→ Common Stock (40,536 underlying) - 10,912
Performance Restricted Stock Units
→ Common Stock (10,912 underlying) - 33,916
Performance Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (33,916 underlying) - 45,220
Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (45,220 underlying) - 13,865
Performance Restricted Stock Units
→ Common Stock (13,865 underlying) - 37,314
Performance Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (37,314 underlying) - 45,923
Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (45,923 underlying) - 26,318
Restricted Stock Units
→ Common Stock (26,318 underlying)
Footnotes (11)
- [F1]Fully exercisable.
- [F10]4,010 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 4,011 restricted stock units vest on 8/15/2027.
- [F11]Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028.
- [F2]Options to purchase 10,134 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
- [F4]Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F5]Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
- [F6]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F7]Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
- [F8]13,159 restricted stock units vest on each of 11/1/2024 and 11/1/2025.
- [F9]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001603594
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 5:30 PM ET
- Size
- 26.1 KB